Patent details

EP1274459 Title: SUSTAINED RELEASE FORMULATIONS COMPRISING GROWTH HORMONE

Basic Information

Publication number:
EP1274459
PCT Application Number:
PCT/US/2001/012909
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019325968
PCT Publication Number:
WO/2001/078683
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SUSTAINED RELEASE FORMULATIONS COMPRISING GROWTH HORMONE
French Title of Invention:
FORMULATIONS A LIBERATION LENTE COMPRENANT UNE HORMONE DE CROISSANCE
German Title of Invention:
FORMULIERUNGEN MIT VERZÖGERTER FREISETZUNG ENTHALTEND WACHSTUMSHORMON
SPC Number:

Dates

Filing date:
19/04/2001
Grant date:
16/11/2005
EP Publication Date:
16/11/2005
PCT Publication Date:
25/10/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/01/2003
EP B1 Publication Date:
16/11/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/04/2006
Expiration date:
19/04/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/04/2001
 
 

Name:
Durect Corporation
Address:
10240 Bubb Road, Cupertino, CA 95014, United States (US)

Name:
GENENTECH INC.
Address:
1 DNA Way, South San Francisco California 94080, United States (US)

Inventor

Name:
OKUMU Franklin
Address:
United States (US)

Priority

Priority Number:
198209 P
Priority Date:
19/04/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 47/26;
Filing date Document type Number of pages